ArticleCancers2024

Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel.

Rodrigo Paredes de la Fuente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.